Walking Fish Therapeutics

Biotechnology
$41.5Mtotal raised · 2 rounds on record
$12.7Mlatest round · Venture round · Feb 2022 · 4 yr ago
50+team · employees, estimated range
2019founded

Overview

ENGINEERING B CELL‐BASED PROTEIN FACTORIES TO TREAT SERIOUS DISEASES. Walking Fish is rapidly advancing cell-based therapeutics to treat serious diseases, concentrating on oncology and regenerative therapies.

Funding and backers

Total raised
$41.5M
2 rounds on record
Latest round
$12.7M
Venture round · Feb 2022 · 4 yr ago
Team
51-200
employees, estimated range
The money's age
Long since its last round
56 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 16, 2022 Raised a round Venture round $12.7M · SEC Form D Aug 27, 2021 Raised a round Venture round $28.8M · SEC Form D 2019 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Feb 2022 $12.7M — SEC Form D
Venture round Aug 2021 $28.8M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Walking Fish Therapeutics, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Lewis WilliamsExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Lightspeed Venture Partners
backs Medikine
NEA
backs Code Biotherapeutics
Oxford Science Enterprises
backs BarinthusBio
Lux Capital
backs Cajal Tx
Sofinnova Partners
backs Redona Therapeutics
Alta Partners
backs Lassen
Similar startupsby what they do, their industry and backers
Vedanta Biosciences, IncVenture round $60M · 3 mo ago · 201-500 employees
Writing the next chapter in GI health. Vedanta is advancing first-in-class Live Biotherapeutic Products (LBP) to treat serious…
Code Biotherapeutics51-200 employees
Code Biotherapeutics is an emerging next-generation gene therapy company pioneering the development of targeted non-viral gene therapies to…
BarinthusBio
Barinthus Biotherapeutic induces T cells and antibodies to treat and prevent disease.
Medikine
A New Generation of Medicines. Engineering cytokine mimetics to change the course of serious diseases.
Redona Therapeutics
Discovering novel therapeutics against enzymes that contribute to the dysregulation of RNA and DNA processes in serious diseases.
LassenVenture round $85M · 2 yr ago
Lassen Therapeutics is developing novel, best-in-class biotherapeutics to improve the lives of patients suffering from serious diseases.

Financials

Total raised
$41.5M
Latest round
Venture - Series Unknown
Funding rounds
2
Funding rounds
Round Announced Amount
Venture - Series Unknown 2022 $12.7M Details
Venture - Series Unknown 2021 $28.8M Details

People

Lewis Williams
Executive Officer, Director
SEC Form D
Franklin Berger
Director
SEC Form D
Antonin de Fougerolles
Director
SEC Form D
Stella Xu
Director
SEC Form D
Alexis Ji
Director
SEC Form D
Momo Wu
Director
SEC Form D
Daniel Janse
Director
SEC Form D
Manish Kothari
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
South San Francisco United States
HQ
50-200 est. staff
280 Utah Avenue, Suite 250 South San Francisco, CA, 94080 United States
company site